For the attention of Community Pharmacies providing the Spring 2024 COVID-19 Community Pharmacy Vaccination Service
Dear Contractor
SPPG have issued correspondence on 19 March 2025 relating to the COVID-19 Spring 2025 Vaccination Programme.
SUMMARY
Community pharmacies who are intending to provide the Spring 2025 COVID-19 vaccine to care homes are requested to complete the online pairing survey by Friday 21 March 2025 if they haven’t already done so.
Any outstanding COVID-CPVS contracts should be submitted by Monday 31 March 2025.
Community pharmacies are requested to conduct a test of VMS before the start of the Spring vaccination programme to ensure there are no issues with access and the system is fully operational.
In relation to VMS accounts:
Primary VMS account:
The password for VMS is the same as the password for the Portal. Changing the password for the Portal will also change the password to VMS.
Second VMS account:
All users have been provided with a second VMS login at the time of the account setup. This password is detailed in the original email that provided the VMS login details and cannot be changed. Please contact Grainne.McMahon4@hscni.net if you have any issues with accessing this account.
Multifactor Authentication (MFA)-on first login there will be a prompt to set up MFA, this can be a different device to that used to authenticate the primary account.
The second account increases access options for VMS meaning two users can access VMS simultaneously which is useful for offsite recording. With two MFA methods, access is not reliant on the availability of a single device.
If there are any issues with accessing VMS, a summary can be emailed to Grainne.McMahon4@hscni.net with a screen shot of the error message.
With regards to the ordering of vaccines from Movianto:
Orders can be placed with Movianto from 31 March 2025.
Turnaround will initially be up to 5 working days for delivery.
Orders should not exceed the quantity required to cover 2 weeks of activity.
Pharmacies not paired with a care home(s) will have a quota set to one box (60 doses).
SPS have produced an SOP that describes the correct use of cool boxes to transport vaccines to other locations (e.g. care homes). This includes validation of a medical grade cool box using a thermometer.
ACTION
Contractors should review the correspondence issued on 19 March 2025 and share this information with relevant members of the pharmacy team.
The Department of Health NI has issued correspondence here dated 14 March 2025 relating to SSP079, SSP080 and SSP081 (Estradot® 50mcg patches, Estradot® 75mcg patches and Estradot® 100mcg patches) extending their expiry dates to Friday 4 April 2025.
BACKGROUND
SSPs made under the Human Medicines Regulations 2012 are an additional tool to manage and mitigate medicines shortages.
SSPs enable community pharmacists to supply specified medicines in accordance with a protocol rather than a prescription, without needing to seek authorisation from the prescriber – saving time for patients, pharmacists and prescribers.
Pharmacists should refer to the latest versions of the existing SSPs which are now available on the Business Services Organisation dedicated page on its website HERE.
Operational guidance on the implementation of SSPs in Northern Ireland can be found on the BSO website HERE.
ACTION
Contractors should:
Review the letter here dated 14 March 2025, and ensure that their dispensary teams are aware of the extension of the expiry dates of SSP079, SSP080 and SSP081 to Friday 4 April 2025, and that they are also aware of the specific details relating to these SSPs; and
Note guidance relating to the decision pathways for SSPs; notification of GPs; the need for patient/carer agreement, and action to take when this is not given; professional judgement; and actions regarding unclear quantities.
Contractors are reminded of information issued by BSO ‘Serious Shortage Protocols: Submission Information for Contractors’ which can be accessed here.
Contractors should contact their local SPPG office in the first instance should further information be required. CPNI colleagues are also available for assistance.
Kind regards
Mike
SENT ON BEHALF OF PROF MIKE MAWHINNEY Head of Regulatory Affairs
This update contains important information for community pharmacy teams.
Representatives from CPNI attended Stormont’s Health Committee on Thursday 6 March 2025.
The discussions can be viewed at the following link.
Marie Curie and RPS Daffodil Standards Launch Event
The Daffodil Standards are a joint initiative between the RPS and Marie Curie and seek to build on the care provided to palliative care patients.
Community pharmacists and members of their team with an interest in palliative care are invited to a launch event at Room 115, Parliament Buildings, Stormont on Monday 31 March 2025 11.30am-1.30pm.
The event will be sponsored by Danny Donnelly MLA and will have a number of key speakers regarding palliative care, with a focus on the importance of the contribution of community pharmacy.
Lunch will also be provided.
If any members of the pharmacy team wish to attend this event, please contact Clare Hunter at CPNI offices.
Autumn 2024/25 Community Pharmacy Flu Vaccination Programme REMINDER:
The Autumn 2024/25 Flu vaccination programme is coming to an end on Monday 31 March 2025.
Providers are requested to not vaccinate eligible cohorts after this date.
Please share this information with all relevant staff to allow adequate time for clinic arrangements and stock management.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor,
SPPG have issued correspondence today providing a funding update for 2024/25 and 2025/26.
2024/25
The letter outlines that 6% inflationary uplifts to global sum and non-global sum budgets have been approved equating to £6.45m. A £4m global sum advance was provided at the start of 2024/25, so a balance of £2.45m remains. The £41k global sum balance will be paid as part of the end of year modulation payment. The non-global sum balance is £2.409m. £2.208m will be paid with the March payment (equating to eleven months) and the remaining £0.201m will be paid with the April payment.
2025/26
The following interventions have been approved:
The DoH(NI) retained margin minimum threshold is being increased from £31.5m to £34m.
From 1st April 2025, the discount deducted (clawback) on appliances will be reduced from 10.39% to 0% (zero discount). This will result in approximately c£2.76m clawback not being deducted from community pharmacy appliance payments in Northern Ireland in 2025/26.
Consideration is also being given by DoH(NI) in respect of 2025/26 inflationary pressures, which will be considered within the Department’s overall Budget Plan in coming weeks.
In the interim, the Global Sum Fees for 2025/26 will remain at current levels:
• Ordinary Dispensing £1.16 per item • Instalment Dispensing £0.44 per item • Practice Allowance £25,728 per year
Any increase to Global Sum Fees will be considered when 2025/26 budgets have been determined and SPPG will liaise with CPNI in this regard.
While these interventions are very much welcomed CPNI considers that the estimated £2.8m associated with appliances moving to zero discount status, should not be included within the table as presented in the SPPG letter as it relates to cost of goods rather than remuneration.
CPNI will keep the network updated on any further developments.
Kind regards,
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
CPNI wishes to make contractors aware of a number of updates in relation to Experiential Learning (EL), and a CPNI survey to collect contractor feedback on the programme. The survey will remain open until 16 April 2025.
SUMMARY
The EL programme commenced in 2023 and is now in its second year with the 2024/2025 programme due to conclude at the end of March 2025.
There are 211 community pharmacies actively participating in the programme, hosting approx. 696 placement weeks for students in the 2024/2025 programme year.
To date, 342 community pharmacists have completed the funded EL practice supervisor (PS) training.
EL is now facilitated in the three main pharmacy sectors – Community, General Practice and Hospital.
There are some key differences in the EL programme in community pharmacy and in general practice. For example:
Community pharmacies host an EL student for 5 days, where they are supported in completing their learning activities by a Practice Supervisor (PS).
General practices host an EL student for 3 days, during which time they are with a PS, and the remaining 2 days are spent in a group learning setting led by a funded GP Pharmacist Educational Lead.
NICPLD has confirmed that separate, additional funding has been provided to the GP Federation to facilitate the 8 x GP Pharmacist Educational Leads.
EL FEEDBACK
NICPLD collects and reviews feedback from EL students and their PS’s during each EL placement block.
Feedback from students and from community pharmacist PSs has been consistently positive.
Feedback from community pharmacy contractors is not routinely collected, however queries, comments and suggestions can be sent by email to h.hirst@qub.ac.uk.
Hospital pharmacists involved in EL have recently raised concerns regarding the number of EL students and have asked for a review of the programme in their setting.
Feedback from GP providers has not yet been shared, however feedback from the small cohort who participated in the 2023/24 programme helped to shape the current adaptations (3 days in practice, with additional funding for 2 days of group learning).
CPNI EL SURVEY
NICPLD has indicated that EL feedback will be used to inform a review of the programme and the development of an ongoing EL strategy.
CPNI has therefore developed a survey to gather views from community pharmacy contractors on what is working well and what changes may benefit the community pharmacy EL programme.
The survey is open to all contractors, regardless of participation in EL, and will remain open until 16 April 2025.
ACTION
Contractors are advised to:
Review the information provided above and share with relevant members of the pharmacy team.
Should you have any questions, please do not hesitate to contact the CPNI team or email Ennis.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
